Enact (ACT) vs Goosehead Insurance (GSHD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Enact (ACT) has outperformed Goosehead Insurance (GSHD) over the past year, gaining 14.8% versus a loss of 34.6%. Over five years, ACT leads with a +106.4% price change compared with -65.5% for GSHD. Enact is the larger company by market cap ($5.94 billion vs $1.67 billion), about 3.6 times the size, while Goosehead Insurance is growing revenue faster (+16.2% vs +2.8%).
On valuation, Enact trades at a lower forward P/E (8.8x vs 17.6x for Goosehead Insurance). Enact pays a dividend yielding 2.04%, while Goosehead Insurance does not currently pay one. Enact converts more of its revenue into profit, with a net margin of 54.6% versus 7.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ACT | GSHD |
|---|---|---|
| Share price | $44.18 | $46.64 |
| Market cap | $5.94B | $1.67B |
| 1-day change | -0.02% | -1.31% |
| YTD return | +11.45% | -36.67% |
| 1-year return | +14.78% | -34.64% |
| 5-year return | +106.45% | -65.49% |
| P/E ratio (TTM) | 9.22 | 34.04 |
| Forward P/E | 8.82 | 17.61 |
| EPS (TTM) | $4.79 | $1.37 |
| Dividend yield | 2.04% | 0.00% |
| Annual dividend | $0.90 | $0.00 |
| Revenue (latest FY) | $1.24B | $365.30M |
| Revenue growth (YoY) | +2.83% | +16.15% |
| Net income (latest FY) | $674.24M | $27.83M |
| Operating margin | — | 20.38% |
| Net margin | 54.56% | 7.62% |
| 52-week high | $50.56 | $79.85 |
| 52-week low | $37.03 | $33.68 |
| Distance from 52-week high | -12.62% | -41.59% |
| Analyst consensus | hold | buy |
| Avg. price target upside | +6.38% | +32.40% |
| Average volume | 422.78K | 442.20K |
| Shares outstanding | 134.44M | 23.80M |
| Employees | 419 | 1,600 |
| Sector | Finance | Finance |
| Industry | Specialty Insurers | Specialty Insurers |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Enact is about 3.6 times larger than Goosehead Insurance by market value ($5.94B vs $1.67B).
- ACT has outperformed GSHD by 49.4 percentage points over the past year.
- Goosehead Insurance trades at a higher earnings multiple (34.0x vs 9.2x trailing P/E).
- Enact offers a meaningfully higher dividend yield (2.04% vs 0.00%).
- Enact is more profitable, keeping 54.6 cents of every revenue dollar as net income versus 7.6 cents for Goosehead Insurance.
- Goosehead Insurance grew revenue faster in its latest fiscal year (+16.15% vs +2.83%).
About Enact
ACT stock →Enact Holdings, Inc. operates as a private mortgage insurance company in the United States.
Finance · Specialty Insurers · 419 employees
About Goosehead Insurance
GSHD stock →Goosehead Insurance, Inc. operates as a holding company for Goosehead Financial, LLC that engages in the provision of personal lines insurance agency services in the United States.
Finance · Specialty Insurers · 1,600 employees
ACT vs GSHD FAQ
Which is bigger, Enact or Goosehead Insurance?
Enact (ACT) is larger, with a market capitalization of $5.94B compared with $1.67B for Goosehead Insurance (GSHD).
Which stock has performed better over the past year, ACT or GSHD?
ACT returned +14.78% over the past 12 months, compared with -34.64% for GSHD (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ACT or GSHD?
ACT has the lower trailing P/E at 9.2, versus 34.0 for GSHD. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Enact or Goosehead Insurance?
Enact pays a dividend yielding 2.04%, while Goosehead Insurance does not currently pay a regular dividend.
Are Enact and Goosehead Insurance in the same industry?
Yes. Both are classified in the Specialty Insurers industry within the Finance sector.